AMEND news in Tag: Adrenocortical Cancer
NETS in RETS
November 10th each year is NET Cancer Day, initiated by the International Neuroendocrine Cancer Alliance, of which AMEND is a member representing genetic neuroendocrine tumour syndromes. To better explain the link between NETs and RETS (rare endocrine tumours and syndromes), join us for our webinar, NETs in RETS, with Professor Karim Meeran on Thursday 9th November from 18:00-19:00.
AMEND Annual Patient Information Day Success
The sun was shining on Saturday 20th May in London for our Annual Patient Information Day, and our venue beside the Regent’s Canal was the perfect place to receive all the members of our rare endocrine diseases communities who had booked to attend.
AMEND Awards 2 Research Grants for 2022
The Trustees are pleased to confirm the AMEND Research Awards for 2022. Our thanks to all the applicants, our judges, the Elliot Dallen Trust and fundraisers, the Akarca brothers.
February 4th is World Cancer Day
The theme for World Cancer Day on February 4th is 'I am, and I will'. Keep an eye out on our social media channels as we raise awareness of the cancers within our community, from adrenocortical cancer, to medullary thyroid cancer and pancreatic neuroendocrine tumours. There will be messages directly from some of our members and plenty to learn throughout the day.